$5.7 Million PSTV Funding

Plus Therapeutics Secures $5.7 Million in Funding to Advance Cancer Research #PSTV News: Plus Therapeutics has successfully closed a private placement with $3.7 million in upfront proceeds and received a $2.0 million advance payment from the Cancer Prevention and...

OSU: New ReSPECT-GBM Site

New Clinical Trial Site Now Enrolling – OSUCCC-James Joins ReSPECT-GBM! We are excited to announce that The Ohio State University Comprehensive Cancer Center – James (OSUCCC – James) has joined our ReSPECT-GBM Clinical Trial as a new investigation site, with Principal...

#WorldCancerDay2025

Honoring Progress and Hope on World Cancer Day 🔬 Today is #WorldCancerDay, a day dedicated to raising awareness, advancing research, and supporting those affected by cancer. At Plus Therapeutics, we recognize the unwavering dedication of patients, caregivers, and...

YouTube Channel

Catch Up on Our Latest Videos – Now on YouTube! Did you miss any of our recent videos? Don’t worry—they’re all available on our Plus Therapeutics YouTube channel! 🔹 Stay informed with expert discussions on cutting-edge cancer research. 🔹 Hear from patients...